We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Using <i>In Vitro</i> Approaches To Investigate Idiosyncratic Drug-Induced Liver Injury
Webinar

Using In Vitro Approaches To Investigate Idiosyncratic Drug-Induced Liver Injury

On Demand
This talk will describe using a combined experimental approach of gene expression profiling, exosome analysis, and high-content imaging in 2D and 3D liver cell culture models to evaluate early IDILI events and risk factors contributing to overt liver injury observed in the clinic.
Extraction E2E: Why Filtration is a Critical Step in Cannabis Oil Processing
Webinar

Extraction E2E: Why Filtration is a Critical Step in Cannabis Oil Processing

On Demand
In this session, Pall Corporation and Evello International will share their best practices on how to optimize your extraction and filtration process.
Massively Parallel CRISPR Genome Editing in S. cerevisiae
Webinar

Massively Parallel CRISPR Genome Editing in S. cerevisiae

On Demand
Understanding how biology works and harnessing its power for biotechnology applications requires powerful tools for manipulating genomes.
Development and Validation of a Duplex qPCR Assay for the Detection of Residual Sf9 Host Cell DNA and Baculovirus DNA
Webinar

Development and Validation of a Duplex qPCR Assay for the Detection of Residual Sf9 Host Cell DNA and Baculovirus DNA

On Demand
Current regulatory authorities (WHO, EMA and US FDA) limited the accepted amounts of residual DNA in biological products making it extremely important to have a sensitive method of quantifying residual host cell DNA. Among the methods of detecting residual DNA, qPCR is the most widely used for residual DNA quantitation due to its sensitivity, accuracy, precision, and time-saving capability.
Critical Raw Material for mRNA-Based Vaccine Development
Webinar

Critical Raw Material for mRNA-Based Vaccine Development

On Demand
Watch this webinar to learn more about the quality requirements for critical raw material for commercial mRNA production and ongoing projects to optimize the entire mRNA portfolio to meet fit-for-purpose standards.
Exploring the Capabilities of a Versatile, Novel, Automated Closed System for Cell and Gene Therapy Manufacturing
Webinar

Exploring the Capabilities of a Versatile, Novel, Automated Closed System for Cell and Gene Therapy Manufacturing

On Demand
New trends and challenges are being identified as more cell and gene therapy institutions move toward clinical trials and into commercialization. Closed manufacturing systems are designed to minimize contamination risks and reduce ISO cleanroom requirements. In combination with digital connectivity, these systems enable repeatable, trackable, and GMP-compliant manufacturing processes.

Advertisement